Moderna providing 500M doses of COVID-19 vaccine to COVAX following WHO approval

Moderna will provide up to 500 million doses of COVID-19 vaccine to COVAX, the U.N.-backed program that provides shots to people in low-and middle-income countries by the end of 2022.